J9228 — Ipilimumab 50 Mg/10 Ml (5 Mg/ml) Intravenous Solution
$56,696
All-payer median here
$210,964
Cash / self-pay here
38
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.